Health ❯ Medicine ❯ Pharmacology

Obesity Treatment

GLP-1 Receptor Agonists GLP-1 Drugs GLP-1 Medications Weight Loss Drugs Semaglutide Weight Loss Medications GLP-1 Analogs Orforglipron Support Cells VK2735 Tirzepatida Tirzepatide Amylin Analogues Clinical Trials TOFA Retatrutide

Berkeley Compound TOFA Cuts Fat in Obese Mice by Raising Energy Use

By increasing whole‑body energy expenditure, TOFA produced large fat loss in mice and could complement appetite‑reducing GLP‑1 drugs.

TOFA Boosts Fat Burning in Mice While Preserving Muscle

Semaglutide Causes Weight Loss by Raising cAMP in Hindbrain Neurons, NIH Study Finds

DNA Links Found for Who Loses Weight and Who Gets Sick on GLP-1 Drugs

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Astrocyte-Derived Peptide Achieves Nausea-Free Weight Loss in Animal Models